Cargando…
Intranasal administration of the chemotherapeutic perillyl alcohol results in selective delivery to the cerebrospinal fluid in rats
Perillyl alcohol (POH) has been extensively studied for the treatment of peripheral and primary brain tumors. The intranasal route of administration has been preferred for dosing POH in early-stage clinical trials associated with promising outcomes in primary brain cancer. However, it is unclear how...
Autores principales: | Nehra, Geetika, Andrews, Shannon, Rettig, Joan, Gould, Michael N., Haag, Jill D., Howard, Steven P., Thorne, Robert G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973779/ https://www.ncbi.nlm.nih.gov/pubmed/33737566 http://dx.doi.org/10.1038/s41598-021-85293-4 |
Ejemplares similares
-
Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol
por: Fonseca, Clovis Orlando da, et al.
Publicado: (2008) -
Intranasal Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and Clinical Development
por: Chen, Thomas C., et al.
Publicado: (2018) -
Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma
por: Schönthal, Axel H, et al.
Publicado: (2021) -
Detection of perillyl alcohol and its metabolite perillic acid in postsurgical glioblastoma tissue after intranasal administration of NEO100: illustrative case
por: Schönthal, Axel H., et al.
Publicado: (2022) -
Adjuvant effect of low-carbohydrate diet on outcomes of patients with recurrent glioblastoma under intranasal perillyl alcohol therapy
por: Santos, Juliana Guimaraes, et al.
Publicado: (2020)